TODAY'S PAPER
74° Good Evening
74° Good Evening
Business

NYU Winthrop wins $100,000 grant to research causes of Alzheimer's

NYU Winthrop Hospital in Mineola has won a

NYU Winthrop Hospital in Mineola has won a $100,000 grant for Alzheimer's research. Photo Credit: NYU Winthrop Hospital

The Alzheimer’s Foundation of America on Tuesday announced a $100,000 grant to NYU Winthrop Hospital in Mineola for a research project to find the underlying causes of Alzheimer’s disease and develop new treatments.

The foundation said the research will re-engineer human blood cells to behave like brain neurons, allowing researchers to achieve what they believe is the closest approximation to brain behavior possible. 

The brain is the body’s most inaccessible and complex organ, and brain tissue is only accessible post-mortem, making it challenging for scientists to develop new treatments and cures, the foundation said in a statement.

“With the number of Americans living with Alzheimer’s disease expected to nearly triple by 2060, the need for a disease-modifying treatment is critical,” said AFA president and CEO Charles J. Fuschillo Jr.  “NYU Winthrop Hospital’s cutting-edge research project has great potential to increase understanding of the causes of Alzheimer’s and lead to a treatment that millions of families are hoping for every single day.”

The project will be led by Dr. Allison Reiss, head of the Inflammation Section at NYU Winthrop Hospital’s Research Institute and associate professor at the NYU Long Island School of Medicine.

Reiss and her team will gather blood samples from individuals living with Alzheimer’s and those without the disease, and re-engineer the collected cells to behave like brain neurons.  The research will isolate and examine “exosomes” — small particles shed from every cell, including neurons in the brain.

These extracellular pieces of neuron, or vesicles, carry genetic information regarding brain neurons and can be extracted from blood.  Researchers will investigate differences in this genetic information between healthy individuals and those with Alzheimer’s and, since these reflect differences in actual brain neurons, plan to use the information gained to reprogram Alzheimer’s neurons to behave more like those in healthy people.

“NYU Winthrop’s non-invasive exosome approach may prove to be one of the best methods for evaluating the human system in order to advance Alzheimer’s research,” Reiss said in a statement. “Examining these particles from brain neurons is like conducting detective work, since they provide clues as to what is actually occurring in the brain itself.”

NYU Winthrop Hospital merged with Manhattan-based NYU Langone earlier this month. Winthrop has been affiliated with NYU since 2017.

Comments

We're revamping our Comments section. Learn more and share your input.

More news